203 related articles for article (PubMed ID: 30684870)
1. A comprehensive review of salinomycin derivatives as potent anticancer and anti-CSCs agents.
Antoszczak M
Eur J Med Chem; 2019 Mar; 166():48-64. PubMed ID: 30684870
[TBL] [Abstract][Full Text] [Related]
2. A medicinal chemistry perspective on salinomycin as a potent anticancer and anti-CSCs agent.
Antoszczak M
Eur J Med Chem; 2019 Feb; 164():366-377. PubMed ID: 30611056
[TBL] [Abstract][Full Text] [Related]
3. Semi-synthetic salinomycin analogs exert cytotoxic activity against human colorectal cancer stem cells.
Klose J; Kattner S; Borgström B; Volz C; Schmidt T; Schneider M; Oredsson S; Strand D; Ulrich A
Biochem Biophys Res Commun; 2018 Jan; 495(1):53-59. PubMed ID: 29107689
[TBL] [Abstract][Full Text] [Related]
4. Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models.
Urbaniak A; Reed MR; Fil D; Moorjani A; Heflin S; Antoszczak M; Sulik M; Huczyński A; Kupsik M; Eoff RL; MacNicol MC; Chambers TC; MacNicol AM
Biomed Pharmacother; 2021 Sep; 141():111815. PubMed ID: 34130123
[TBL] [Abstract][Full Text] [Related]
5. Semisynthesis of SY-1 for investigation of breast cancer stem cell selectivity of C-ring-modified salinomycin analogues.
Huang X; Borgström B; Månsson L; Persson L; Oredsson S; Hegardt C; Strand D
ACS Chem Biol; 2014 Jul; 9(7):1587-94. PubMed ID: 24841425
[TBL] [Abstract][Full Text] [Related]
6. Co-Eradication of Breast Cancer Cells and Cancer Stem Cells by Cross-Linked Multilamellar Liposomes Enhances Tumor Treatment.
Kim YJ; Liu Y; Li S; Rohrs J; Zhang R; Zhang X; Wang P
Mol Pharm; 2015 Aug; 12(8):2811-22. PubMed ID: 26098197
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogs.
Huang X; Borgström B; Kempengren S; Persson L; Hegardt C; Strand D; Oredsson S
BMC Cancer; 2016 Feb; 16():145. PubMed ID: 26906175
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Anticancer Activity of Dimeric Polyether Ionophores.
Sulik M; Maj E; Wietrzyk J; Huczyński A; Antoszczak M
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32664671
[TBL] [Abstract][Full Text] [Related]
9. Polymeric Micellar Formulation Enhances Antimicrobial and Anticancer Properties of Salinomycin.
Sousa C; Gouveia LF; Kreutzer B; Silva-Lima B; Maphasa RE; Dube A; Videira M
Pharm Res; 2019 Apr; 36(6):83. PubMed ID: 30989413
[TBL] [Abstract][Full Text] [Related]
10. Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells.
Ni M; Xiong M; Zhang X; Cai G; Chen H; Zeng Q; Yu Z
Int J Nanomedicine; 2015; 10():2537-54. PubMed ID: 25848270
[TBL] [Abstract][Full Text] [Related]
11. Salinomycin and its derivatives - A new class of multiple-targeted "magic bullets".
Antoszczak M; Huczyński A
Eur J Med Chem; 2019 Aug; 176():208-227. PubMed ID: 31103901
[TBL] [Abstract][Full Text] [Related]
12. Differences in Antiproliferative Activity Between Salinomycin-AZT Conjugates Obtained via 'Click' and Esterification Reactions.
Antoszczak M; Maj E; Kleczewska N; Wietrzyk J; Celewicz L; Huczynski A
Med Chem; 2017; 13(2):127-136. PubMed ID: 27557629
[TBL] [Abstract][Full Text] [Related]
13. Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics.
Boesch M; Zeimet AG; Rumpold H; Gastl G; Sopper S; Wolf D
Stem Cells Transl Med; 2015 Sep; 4(9):1028-32. PubMed ID: 26136502
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Anticancer Activity of Tertiary Amides of Salinomycin and Their C20-oxo Analogues.
Czerwonka D; Urbaniak A; Sobczak S; Piña-Oviedo S; Chambers TC; Antoszczak M; Huczyński A
ChemMedChem; 2020 Jan; 15(2):236-246. PubMed ID: 31702860
[TBL] [Abstract][Full Text] [Related]
15. Singly and doubly modified analogues of C20-epi-salinomycin: A new group of antiparasitic agents against Trypanosoma brucei.
Czerwonka D; Barcelos Y; Steverding D; Cioch A; Huczyński A; Antoszczak M
Eur J Med Chem; 2021 Jan; 209():112900. PubMed ID: 33071053
[TBL] [Abstract][Full Text] [Related]
16. Self-targeted salinomycin-loaded DSPE-PEG-methotrexate nanomicelles for targeting both head and neck squamous cell carcinoma cancer cells and cancer stem cells.
Zhu M; Chen S; Hua L; Zhang C; Chen M; Chen D; Dong Y; Zhang Y; Li M; Song X; Chen H; Zheng H
Nanomedicine (Lond); 2017 Feb; 12(4):295-315. PubMed ID: 28093940
[TBL] [Abstract][Full Text] [Related]
17. Overcoming Resistance to Platinum-Based Drugs in Ovarian Cancer by Salinomycin and Its Derivatives-An In Vitro Study.
Michalak M; Lach MS; Antoszczak M; Huczyński A; Suchorska WM
Molecules; 2020 Jan; 25(3):. PubMed ID: 31991882
[TBL] [Abstract][Full Text] [Related]
18. Anticancer Activity of Polyether Ionophore-Salinomycin.
Antoszczak M; Huczyński A
Anticancer Agents Med Chem; 2015; 15(5):575-91. PubMed ID: 25553435
[TBL] [Abstract][Full Text] [Related]
19. Salinomycin derivatives exhibit activity against primary acute lymphoblastic leukemia (ALL) cells in vitro.
Urbaniak A; Delgado M; Antoszczak M; Huczyński A; Chambers TC
Biomed Pharmacother; 2018 Mar; 99():384-390. PubMed ID: 29367107
[TBL] [Abstract][Full Text] [Related]
20. Salinomycin, as an autophagy modulator-- a new avenue to anticancer: a review.
Jiang J; Li H; Qaed E; Zhang J; Song Y; Wu R; Bu X; Wang Q; Tang Z
J Exp Clin Cancer Res; 2018 Feb; 37(1):26. PubMed ID: 29433536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
